Landmark Financial Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
$958K Hold
6,181
0.34% 39
2023
Q3
$921K Hold
6,181
0.37% 39
2023
Q2
$833K Sell
6,181
-250
-4% -$33.7K 0.34% 42
2023
Q1
$1.02M Sell
6,431
-28
-0.4% -$4.46K 0.45% 39
2022
Q4
$1.04M Sell
6,459
-250
-4% -$40.4K 0.48% 34
2022
Q3
$900K Sell
6,709
-1
-0% -$134 0.48% 34
2022
Q2
$1.03M Sell
6,710
-241
-3% -$36.9K 0.51% 29
2022
Q1
$1.09M Buy
6,951
+241
+4% +$37.7K 0.52% 28
2021
Q4
$909K Buy
6,710
+67
+1% +$9.08K 0.4% 36
2021
Q3
$719K Sell
6,643
-147
-2% -$15.9K 0.39% 34
2021
Q2
$765K Buy
6,790
+147
+2% +$16.6K 0.37% 35
2021
Q1
$719K Hold
6,643
0.39% 34
2020
Q4
$724K Buy
6,643
+509
+8% +$55.5K 0.41% 34
2020
Q3
$539K Sell
6,134
-187
-3% -$16.4K 0.34% 38
2020
Q2
$626K Buy
6,321
+27
+0.4% +$2.67K 0.41% 33
2020
Q1
$517K Sell
6,294
-41
-0.6% -$3.37K 0.35% 35
2019
Q4
$540K Hold
6,335
0.31% 35
2019
Q3
$479K Hold
6,335
0.3% 35
2019
Q2
$460K Buy
6,335
+5
+0.1% +$363 0.28% 34
2019
Q1
$510K Buy
6,330
+5
+0.1% +$403 0.33% 34
2018
Q4
$583K Buy
6,325
+3
+0% +$277 0.38% 33
2018
Q3
$597K Buy
6,322
+3
+0% +$283 0.36% 33
2018
Q2
$585K Buy
6,319
+86
+1% +$7.96K 0.36% 31
2018
Q1
$590K Buy
6,233
+2
+0% +$189 0.37% 31
2017
Q4
$602K Buy
6,231
+2
+0% +$193 0.38% 31
2017
Q3
$554K Buy
6,229
+3
+0% +$267 0.37% 30
2017
Q2
$451K Buy
6,226
+3
+0% +$217 0.32% 35
2017
Q1
$406K Buy
6,223
+3
+0% +$196 0.3% 35
2016
Q4
$390K Buy
6,220
+83
+1% +$5.2K 0.31% 36
2016
Q3
$387K Buy
6,137
+403
+7% +$25.4K 0.33% 36
2016
Q2
$355K Buy
5,734
+3
+0.1% +$186 0.33% 40
2016
Q1
$327K Buy
5,731
+203
+4% +$11.6K 0.33% 39
2015
Q4
$327K Buy
5,528
+2
+0% +$118 0.34% 35
2015
Q3
$300K Buy
5,526
+3
+0.1% +$163 0.33% 32
2015
Q2
$371K Buy
5,523
+2
+0% +$134 0.38% 33
2015
Q1
$323K Buy
5,521
+169
+3% +$9.89K 0.34% 35
2014
Q4
$355K Buy
+5,352
New +$355K 0.37% 34